SWITZERLAND SWISS LEADER Stock

Index

Market Closed - Swiss Exchange 07:06:00 24/10/26 am AEDT			5-day change	1st Jan Change
2,325.30 ^PTS	-0.20%		+0.80%	+8.49%

22/10	Galderma lifts outlook for second quarter in a row after sales jump	RE
12/10	Ascend Sport Technology to List on SIX Swiss Exchange via EvoNext Merger	MT

22/10	Galderma lifts outlook for second quarter in a row after sales jump	RE
12/10	Ascend Sport Technology to List on SIX Swiss Exchange via EvoNext Merger	MT
02/10	UBS Group to Redeem JPY8.3 Billion Senior Callable Notes	MT
02/10	WISeKey International Completes Redomiciliation to British Virgin Islands	MT
01/10	SIX Group Logs Higher Turnover from Swiss, Spanish Bourses in September	MT
01/10	Infomaniak Debuts on SIX Swiss Exchange After Reverse Takeover of Perrot Duval	MT
27/09	WISeKey International Set to Close Redomiciliation, Merger with WISeQey	MT
25/09	WISeKey's British Virgin Islands Unit Renames to WISeQey Ahead of Merger	MT
21/09	Galderma joins the SMI index and raises sales growth target
15/09	Hansainvest Lists ETF on SIX Swiss Exchange	MT
10/09	Wealth Manager Pictet Issues AI-Enhanced ETFs on SIX Swiss Exchange	MT
09/09	HSBC to Redeem CHF300 Million Notes in November	MT
09/09	Vaudoise Assurances to Issue CHF220 Million of Bonds	MT

24/10	Health Care Down as Rotation From AI Cos Slows - Health Care Roundup	DJ
24/10	Novartis Says Remibrutinib Delivers Disease Control in Phase 3 Relapsing Multiple Sclerosis Trials	MT
24/10	Novartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib	RE
24/10	Novartis U.S. Shares Fall After MS Pill Trial Data Disappoint	DJ
24/10	BofA Lifts Galderma Price Objective, Forecasts After Q3 Sales Beat	MT
24/10	Novartis Says MS Pill Helped Control Disease With Favorable Safety Data in Trials	DJ
24/10	Swiss Market Index Ends Week on Negative Note; Sika, Novartis Shares Down	MT
24/10	Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile	DJ
24/10	Bristol Myers discloses patient death in early-stage cell therapy study	RE
23/10	Deutsche Bank Research Upgrades Roche to Buy, Boosts PT	MT

No results match your criteria

24/10	Les Bourses mondiales dans le rouge, entre envolée du pétrole et dette française
24/10	Les Bourses mondiales sans entrain, la dette française attend Moody's
24/10	Bourse Zurich: dans le rouge pour terminer la semaine
24/10	Aktien Schweiz Schluss: Gewinnmitnahmen zum Wochenende - Holcim sehr stark
24/10	Borsa svizzera: chiude in ribasso, SMI -0,59%